<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02126657</url>
  </required_header>
  <id_info>
    <org_study_id>2013/01230</org_study_id>
    <nct_id>NCT02126657</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars</brief_title>
  <official_title>Phase 2 Study of the The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study involves the evaluation of a high potency chemical peel in its efficacy and safety&#xD;
      profile for the treatment of acne scars. This chemical peel regime is a high potency peel of&#xD;
      70% glycolic acid combined with vitamin C that is purported to provide a good balance between&#xD;
      yielding results and patient safety. We aim to evaluate its efficacy and safety profile of a&#xD;
      single application. The study design is based on a single group that compares pre- vs&#xD;
      post-intervention. 10 patients with atrophic acne scars of skin type I-IV will be recruited.&#xD;
      Potential benefits include improvement of post acne scars with a short downtime and risks&#xD;
      include post peel hyper pigmentation and scarring. We believe that this treatment will be&#xD;
      highly beneficial to patients with post acne scarring.&#xD;
&#xD;
      This chemical peel regime has good efficacy and safety profile for the treatment of acne&#xD;
      scars.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary endpoints:&#xD;
&#xD;
        1. ECCA (échelle d'évaluation clinique des cicatrices d'acné) grading scale for&#xD;
           quantitative grading of acne scars. Two blinded evaluators compare and rate the&#xD;
           photograph using ECCA score.&#xD;
&#xD;
        2. Patient Assessment Based on 1 to 10 point scale; 1- nil acne scars and 10- severe acne&#xD;
           scar&#xD;
&#xD;
      Secondary endpoints:&#xD;
&#xD;
        1. Postacne hyperpigmentation index (PAHPI)&#xD;
&#xD;
           -Each of these 3 variables --size, intensity, and number of lesions is weighted and the&#xD;
           summation of the weighted variables gives the total PAHPI score, ranging 6 to 22.&#xD;
&#xD;
        2. Safety Assessment (This is an ordinal scale) i. Score of redness ii. Score of swelling&#xD;
           iii. Score of oozing/crusting iv. Post peel hyperpigmentation v. Post peel scarring vi.&#xD;
           Assessment based on patient and doctor global assessment (global assessment from 1 - 10)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy Assessment</measure>
    <time_frame>3 months</time_frame>
    <description>ECCA (échelle d'évaluation clinique des cicatrices d'acné) grading scale for quantitative grading of acne scars&#xD;
V-shaped atrophic scars with diameter &lt;2 mm: 15&#xD;
U-shaped atrophic scars with a diameter of 2-4 mm: 20&#xD;
M-shaped atrophic scars with diameter &gt;4 mm: 25&#xD;
Superficial elastolysis: 30&#xD;
Hypertrophic scars with a &lt;2-year duration: 40&#xD;
Hypertrophic scars of &gt;2-year duration: 50 A semi-quantitative scoring of number of each scar will be performed&#xD;
No scars: 0&#xD;
Less than five scars: 1&#xD;
Between five and 20 scars: 2&#xD;
More than 20 scars: 3&#xD;
Patient Assessment Based on 1 to 10 point scale; 1- nil acne scars and 10- severe acne scar&#xD;
Secondary endpoints&#xD;
1) Postacne hyperpigmentation index (PAHPI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Assessment</measure>
    <time_frame>3 months</time_frame>
    <description>) Safety Assessment (This is also an ordinal scale) i. Score of redness ii. Score of swelling iii. Score of oozing/crusting iv. Post peel hyperpigmentation v. Post peel scarring</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Acne Scars</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm study - pre and post peel assessment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>70% glycolic acid</intervention_name>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Atrophic scars&#xD;
&#xD;
          2. Skin type I to IV&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy, breastfeeding&#xD;
&#xD;
          2. Active dermatitis (on the face), rosacea, allergic rhinitis, active herpes simplex&#xD;
&#xD;
          3. Known hypersensitivity&#xD;
&#xD;
          4. Previous keloids&#xD;
&#xD;
          5. Laser ablative procedures within the last month&#xD;
&#xD;
          6. Chemical peels within the last 6 months&#xD;
&#xD;
          7. Used oral retinoids in the past 6 months&#xD;
&#xD;
          8. Used topical retinoids in the past one week&#xD;
&#xD;
          9. Used scrub, AHA, skin irritant for the past 24h&#xD;
&#xD;
         10. Presence of facial warts or fungal infections&#xD;
&#xD;
         11. Photoallergies&#xD;
&#xD;
         12. Prior poor reaction to a chemical peel&#xD;
&#xD;
         13. Radiotherapy&#xD;
&#xD;
         14. Skin type V and VI&#xD;
&#xD;
         15. Patients with predominantly ice pick and boxcar scars&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sam SY Yang, Dr</last_name>
    <phone>85333992</phone>
    <email>samsyyang@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <contact>
      <last_name>Sam Yang, Dr</last_name>
      <phone>85333992</phone>
      <email>samsyyang@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <study_first_submitted>April 28, 2014</study_first_submitted>
  <study_first_submitted_qc>April 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2014</study_first_posted>
  <last_update_submitted>April 28, 2014</last_update_submitted>
  <last_update_submitted_qc>April 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acne scars</keyword>
  <keyword>70% Glycolic acid peel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycolic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

